Published in Eur Respir J on February 01, 1993
Efficacy and safety of 4 weeks' treatment with combined fluticasone furoate/vilanterol in a single inhaler given once daily in COPD: a placebo-controlled randomised trial. BMJ Open (2012) 1.13
Systemic effects of formoterol and salmeterol: a dose-response comparison in healthy subjects. Thorax (2000) 1.06
Systemic and bronchodilator effects of inhaled rac-formoterol in subjects with chronic obstructive pulmonary disease: a dose-response study. Br J Clin Pharmacol (2008) 0.98
The use of β2-agonist therapy before hospital attendance for severe asthma exacerbations: a post-hoc analysis. NPJ Prim Care Respir Med (2015) 0.95
Clinical implications of the intrinsic efficacy of beta-adrenoceptor drugs in asthma: full, partial and inverse agonism. Curr Opin Pulm Med (2010) 0.87
Indacaterol, A Novel Once Daily Inhaled beta2-Adrenoreceptor Agonist. Open Respir Med J (2009) 0.84
Arrhythmia in the neonatal intensive care unit. Pediatr Cardiol (2009) 0.78
Safety of daily albuterol in infants with a history of bronchospasm: a multi-center placebo controlled trial. Open Respir Med J (2009) 0.75
Effect of bronchodilatation on single breath pulmonary uptake of carbon monoxide in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis (2006) 0.75
Therapeutic effects of the combination of inhaled beta2-agonists and beta-blockers in COPD patients with cardiovascular disease. Heart Fail Rev (2017) 0.75
International Study of Asthma and Allergies in Childhood (ISAAC): rationale and methods. Eur Respir J (1995) 13.01
Prescribed fenoterol and death from asthma in New Zealand, 1981-83: case-control study. Lancet (1989) 5.82
Risk factors for delayed presentation and referral of symptomatic cancer: evidence for common cancers. Br J Cancer (2009) 5.10
End of the New Zealand asthma mortality epidemic. Lancet (1995) 4.88
Epidemiology and costs of chronic obstructive pulmonary disease. Eur Respir J (2006) 3.89
Worldwide variations in the prevalence of symptoms of atopic eczema in the International Study of Asthma and Allergies in Childhood. J Allergy Clin Immunol (1999) 3.87
Global variation in the prevalence and severity of asthma symptoms: phase three of the International Study of Asthma and Allergies in Childhood (ISAAC). Thorax (2009) 3.72
Subepithelial fibrosis in the bronchi of asthmatics. Lancet (1989) 3.70
Non-eosinophilic asthma: importance and possible mechanisms. Thorax (2002) 3.53
Prescribed fenoterol and death from asthma in New Zealand, 1981-7: a further case-control study. Thorax (1991) 3.39
Beta agonists and asthma mortality: déjà vu. Clin Exp Allergy (1991) 3.39
Frequency of venous thromboembolism in low to moderate risk long distance air travellers: the New Zealand Air Traveller's Thrombosis (NZATT) study. Lancet (2003) 3.34
Bioaerosol health effects and exposure assessment: progress and prospects. Ann Occup Hyg (2003) 3.32
Worldwide worsening wheezing--is the cure the cause? Lancet (1992) 3.30
Cannabis use and risk of lung cancer: a case-control study. Eur Respir J (2008) 3.29
Comparison of potency of inhaled beclomethasone and budesonide in New Zealand: retrospective study of computerised general practice records. BMJ (1998) 3.15
Cancer mortality in workers exposed to phenoxy herbicides, chlorophenols, and dioxins. An expanded and updated international cohort study. Am J Epidemiol (1997) 3.10
How much asthma is really attributable to atopy? Thorax (1999) 3.04
Case-control study of prescribed fenoterol and death from asthma in New Zealand, 1977-81. Thorax (1990) 3.02
COPD prevalence in a random population survey: a matter of definition. Eur Respir J (2007) 2.97
Diarrhea in developed and developing countries: magnitude, special settings, and etiologies. Rev Infect Dis (1990) 2.81
The international study of asthma and allergies in childhood (ISAAC): phase three rationale and methods. Int J Tuberc Lung Dis (2005) 2.65
The self-administration of inhaled beta agonist drugs during severe asthma. N Z Med J (1990) 2.61
Asthma mortality and inhaled beta agonist therapy. Aust N Z J Med (1991) 2.61
Retrofitting houses with insulation to reduce health inequalities: aims and methods of a clustered, randomised community-based trial. Soc Sci Med (2005) 2.54
Development of a questionnaire measure of adjustment to cancer: the MAC scale. Psychol Med (1988) 2.53
Variability in antihypertensive drug therapy in general practice: results from a random national survey. N Z Med J (1989) 2.47
Distinct clinical phenotypes of airways disease defined by cluster analysis. Eur Respir J (2009) 2.37
Meta-analysis of the risk of mortality with salmeterol and the effect of concomitant inhaled corticosteroid therapy. Thorax (2010) 2.36
Pre-hospital oxygen therapy in acute exacerbations of chronic obstructive pulmonary disease. Intern Med J (2010) 2.27
The relationship of per capita gross national product to the prevalence of symptoms of asthma and other atopic diseases in children (ISAAC). Int J Epidemiol (2001) 2.27
Radiation doses and cause-specific mortality among workers at a nuclear materials fabrication plant. Am J Epidemiol (1988) 2.25
Prevalence and etiology of asthma. J Allergy Clin Immunol (2000) 2.19
Passive smoking and passive thinking. N Z Med J (1989) 2.17
Worldwide variations in prevalence of symptoms of allergic rhinoconjunctivitis in children: the International Study of Asthma and Allergies in Childhood (ISAAC). Pediatr Allergy Immunol (1997) 2.15
Beta-agonist therapy and asthma mortality in Japan. Lancet (1998) 2.06
Baseline risk for asthma deaths. N Z Med J (1992) 2.02
Quality of life measured by the St George's Respiratory Questionnaire and spirometry. Eur Respir J (2009) 1.99
A prospective randomized trial of external fixation and plaster cast immobilization in the treatment of distal radial fractures. J Orthop Trauma (1990) 1.97
Perinatal factors and atopic disease in childhood. Clin Exp Allergy (1997) 1.96
Moderate dose inhaled corticosteroids plus salmeterol versus higher doses of inhaled corticosteroids in symptomatic asthma. Thorax (2005) 1.95
Is infant immunization a risk factor for childhood asthma or allergy? Epidemiology (1997) 1.94
Markers of risk of asthma death or readmission in the 12 months following a hospital admission for asthma. Int J Epidemiol (1992) 1.92
Receptor-triggered membrane association of a model retroviral glycoprotein. Proc Natl Acad Sci U S A (1998) 1.91
House dust mite allergen (Der p 1) accumulation on new synthetic and feather pillows. Clin Exp Allergy (1999) 1.89
Defining asthma in epidemiological studies. Eur Respir J (1999) 1.88
Does environmental endotoxin exposure prevent asthma? Thorax (2002) 1.88
Cardiovascular and hypokalaemic effects of inhaled salbutamol, fenoterol, and isoprenaline. Thorax (1989) 1.87
Occupational asthma in New Zealanders: a population based study. Occup Environ Med (1997) 1.84
House dust mite allergen in pillows. BMJ (1996) 1.83
Obesity and asthma in 11-12 year old New Zealand children in 1989 and 2000. Thorax (2005) 1.82
Prevalence of symptoms of asthma, rhinitis and eczema in 13- to 14-year-old children in Africa: the International Study of Asthma and Allergies in Childhood Phase III. Allergy (2007) 1.81
The effects of early and late paracetamol exposure on asthma and atopy: a birth cohort. Clin Exp Allergy (2010) 1.79
The ecological fallacy strikes back. J Epidemiol Community Health (2000) 1.79
Routine use of oxygen in the treatment of myocardial infarction: systematic review. Heart (2008) 1.78
Latency analysis in occupational epidemiology. Arch Environ Health (1990) 1.77
Community-based asthma care: trial of a "credit card" asthma self-management plan. Eur Respir J (1994) 1.76